PT  - JOURNAL ARTICLE
AU  - Waksman, Ron
TI  - A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds
AID  - 10.3949/ccjm.84.s4.05
DP  - 2017 Dec 01
TA  - Cleveland Clinic Journal of Medicine
PG  - e20--e24
VI  - 84
IP  - 12 suppl 4
4099  - http://www.ccjm.org/content/84/12_suppl_4/e20.short
4100  - http://www.ccjm.org/content/84/12_suppl_4/e20.full
SO  - Cleve Clin J Med2017 Dec 01; 84
AB  - Drug-eluting stents (DES) are increasingly being used as a less invasive alternative to coronary artery bypass grafting. Early generation DES had durable polymers that provided acceptable efficacy outcomes but had high rates of stent thrombosis leading to myocardial infarction and death. Second-generation DES have improved outcomes by reducing stent thrombosis and recurrent stenosis. Newer DES with biodegradable polymers have similar efficacy as second-generation DES, but have higher rates of stent thrombosis. This review compares outcomes of bioresorbable scaffolds and looks at stent technology developments that may improve outcomes.